16views
We are back!
After more than a year on the back-burner, CannabisIntel has re-engaged with an editor and will be publishing articles and news about the Australian and international medicinal cannabis industry.
The last year has seen a lot of changes in the industry here in Australia, from more players bringing products on the market and dropping prices to the TGA announcing their plans to add low-dose CBD to Schedule 3.
Watch this space to keep up with daily news and activity!
add a comment
